General American Investors CO Inc Biohaven Pharmaceutical Holding CO Ltd. Transaction History

General American Investors CO Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$65.78 - $105.02 $2.96 Million - $4.73 Million	-45,000 Closed	0 $0
Q2 2020 Aug 03, 2020	SELL	$29.01 - $74.23 $580,200 - $1.48 Million	-20,000 Reduced 30.77%	45,000 $3.29 Million
Q1 2020 May 01, 2020	BUY	$27.51 - $57.29 $1.79 Million - $3.72 Million	65,000 New	65,000 $2.21 Million

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.32B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of General American Investors CO Inc, based on Form 13F filings with the SEC.

Stay updated on General American Investors CO Inc with notifications on news.